Nanobiotix S.A.

NASDAQ:NBTX

Biotechnology

Healthcare
$27.32 -0.91%

-$0.33 today

Market cap
$1.39B
Beta
0.59
P/E (TTM)
-60.2
EPS (TTM)
-$0.51
52W Low $4.31High $57.14

Volume 0.18M

Average 0.08M

Balance Sheet

Inspect the capital base behind the business.

Assets

$67.76M

FY 2025 · Annual

+0.5% YoY

Liabilities

$152.24M

FY 2025 · Annual

+14.4% YoY

Equity

-$84.48M

FY 2025 · Annual

Balance Sheet

EUR
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents83.92M41.39M75.28M49.74M52.75M
Short-term Investments00000
Net Receivables3.89M2.84M2.97M8.54M7.68M
Inventory02.98M200K00
Other Current Assets3.04M2.17M6.33M(1K)2K
Total Current Assets93.06M52.36M87.34M61.47M62.75M
Property, Plant & Equipment (Net)8.19M7.12M6.11M5.54M4.57M
Goodwill00000
Intangible Assets4K1K8K7K10K
Long-term Investments98K0000
Tax Assets00000
Other Non-current Assets421K291K443K406K434K
Total Non-current Assets8.71M7.41M6.56M5.95M5.01M
Total Assets101.77M59.77M93.9M67.42M67.76M
Account Payables5M4M6.7M4.48M6.58M
Short-term Debt7.08M3.6M3.82M3.66M3.1M
Tax Payables5.08M6.6M7.38M6.87M6.82M
Deferred Revenue16.77M16.57M18.23M18.16M36.22M
Other Current Liabilities5.39M7.41M760K8.27M430K
Total Current Liabilities36.85M37.94M49.87M58.94M57.51M
Long-term Debt32.42M44.04M41.66M43.01M89.12M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities318K270K325K28.21M3.73M
Total Non-current Liabilities38.13M48.88M45.87M74.19M94.74M
Total Liabilities74.98M86.81M95.74M133.12M152.24M
Common Stock1.05M1.05M1.41M1.42M1.45M
Retained Earnings(47M)(57.04M)(39.7M)(68.13M)(23.96M)
Accumulated OCI(182.82M)(226.58M)(276.07M)(311.51M)(376.15M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity26.79M(27.05M)(1.84M)(65.7M)(84.48M)
Total Debt46.02M53.17M50.57M50.9M95.32M
Net Debt(37.9M)11.78M(24.72M)1.17M42.57M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$52.8M
Receivables$7.7M
Other Current$2.3M
Total Current Assets$62.8M
PP&E (Net)$4.6M
Intangible Assets$10.0K
Other Non-current$434.0K
Total Non-current Assets$5.0M
Total Assets$67.8M

Analysis

Selected assets total $67.8M for Latest. The largest visible component is Cash & Equivalents at $52.8M, about 77.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 12, 2026
6-K6-K filingNov 9, 2026
6-K6-K filingOct 26, 2026
6-K6-K filingOct 20, 2026
6-K6-K filingOct 1, 2026

How much cash does NBTX have?

Nanobiotix S.A. (NBTX) reported $52.75M in cash and equivalents in fiscal 2025.

How much debt does NBTX carry?

Nanobiotix S.A. (NBTX) reported $95.32M of total debt, with net debt of $42.57M.